<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03857750</url>
  </required_header>
  <id_info>
    <org_study_id>H-18063017</org_study_id>
    <nct_id>NCT03857750</nct_id>
  </id_info>
  <brief_title>Neuromuscular Blocking Agents in the Elderly</brief_title>
  <official_title>An Observational Study of Rocuronium 0.6 mg/kg Comparing Onset Time, Duration of Action and Effect on Intubation Conditions in Younger (18 - 40 Years) and Elderly Patients (&gt; 80 Years)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The number of elderly patients (&gt;80 years) is increasing and a large proportion of these
      patients will require surgery and anaestheasia within the next decades.

      During anaesthesia NMBAs are used to facilitate tracheal intubation, from former studies it
      is reported that elderly patients are more sensitive towards muscle relaxants.

      It is unknown if there are differences in onset times of NMBAs between younger patients and
      elderly.

      The aim of this study is to determine the onset time, duration of action and effect on
      intubating conditions for rocuronium 0.6 mg/kg in patients aged 18-40 years and in patiens
      &gt;80 years. The hypothesis of this study is that rocuronium administered in elderly patients
      (&gt;80 years) has a longer onset time compared to younger patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The number of elderly patients (&gt;80 years) is increasing and a large proportion of these
      patients will require surgery and anesthesia within the next decades. Elderly patients are at
      higher risk of major morbidity and mortality and are characterized by a reduction in cardiac
      output, liver function and renal function. These physiological changes influence
      pharmacodynamics and pharmacokinetics of drugs administered during anesthesia as for example
      neuromuscular blocking agents (NMBA).

      During anesthesia NMBAs are used to facilitate tracheal intubation, establish muscle
      relaxation and suppress reflexes during surgery. Elderly patients are more sensitive towards
      muscle relaxants. In addition studies have reported prolonged duration of NMBAs and an
      observational study found that elderly patients are more prone to experience residual
      neuromuscular blockade in the post anesthesia care unit. However, most studies have been
      conducted in elderly below 80 years.

      It is unknown if there are differences in onset times of NMBAs e.g. rocuronium, mivacurium
      and cisatracurium between younger patients and elderly. Onset time for NMBAs in the elderly
      is of importance since it may influence intubating conditions, especially during rapid
      sequence induction. For example it is unknown in the elderly if an increased dose of NMBA
      reduces the onset time. There remains a need for studies investigating the optimal dose for
      facilitating intubation in the elderly, both during rapid sequence induction and during
      elective procedures.

      The aim of this study is to determine the onset time, duration of action and effect on
      intubating conditions for rocuronium 0.6 mg/kg in patients aged 18-40 years and in patients
      with age &gt; 80 years. The hypothesis of this study is that rocuronium administered in elderly
      patients (&gt;80 years) has a longer onset in the elderly compared to younger patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 27, 2019</start_date>
  <completion_date type="Actual">October 8, 2019</completion_date>
  <primary_completion_date type="Actual">October 8, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Onset Time</measure>
    <time_frame>Day 0, after induction of anesthesia</time_frame>
    <description>The time from the end of rocuronium injection to train-of-four (TOF) count of 0 monitored by acceleromyography.
The ulnar nerve was stimulated during the monitoring.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparing Intubating Conditions in the Two Groups</measure>
    <time_frame>Day 0, after induction of anesthesia</time_frame>
    <description>90 seconds after induction the conditions are rated by the Intubating Difficulty Scale (IDS).
Easy is defined as IDS of 0. Slight is defined as IDS of 1 to 5 Moderate/Major is defined as &gt;5</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Action</measure>
    <time_frame>Day 0, after induction of anesthesia</time_frame>
    <description>Time from end of rocuronium injection to TOF ratio &gt;0.9. When the ratio between the first and last stimulation in TOF is above 90 %.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">32</enrollment>
  <condition>Elective Surgery</condition>
  <arm_group>
    <arm_group_label>Elderly (&gt;80 years)</arm_group_label>
    <description>Patients planned for elective surgery above 80 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Younger (18-40 years)</arm_group_label>
    <description>Patients planned for elective surgery between 18-40 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium</intervention_name>
    <description>0.6 mg/kg</description>
    <arm_group_label>Elderly (&gt;80 years)</arm_group_label>
    <arm_group_label>Younger (18-40 years)</arm_group_label>
    <other_name>Rocuronium 0.6 mg/kg</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        32 patients Group young: 16 patients age between 18-40 years receiving rocuronium 0.6 mg/kg
        Group elderly: 16 patients age &gt;80 years receiving rocuronium 0.6 mg/kg
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 18 years old

          -  Informed consent

          -  Scheduled for elective surgery (&gt;1 hour) under general anaesthesia with intubation and
             use of rocuronium.

          -  American Society of Anaesthesiologists (ASA) physical status classification I to III

          -  Can read and understand Danish

        Exclusion Criteria:

          -  Known allergy to rocuronium

          -  Neuromuscular disease that may interfere with neuromuscular data

          -  Indication for rapid sequence induction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matias Vested, MD, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 25, 2019</study_first_submitted>
  <study_first_submitted_qc>February 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2019</study_first_posted>
  <results_first_submitted>January 27, 2020</results_first_submitted>
  <results_first_submitted_qc>May 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 2, 2020</results_first_posted>
  <last_update_submitted>May 18, 2020</last_update_submitted>
  <last_update_submitted_qc>May 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Matias Vested</investigator_full_name>
    <investigator_title>Principal Investigator, Medical Doctor, PhD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 6, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/50/NCT03857750/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were included from the Departments of Anaesthesia, Centre of Head and Orthopaedics and Juliane Marie Centre, Rigshospitalet, University of Copenhagen, Denmark in the period of the 27th of March 2019 to 7th of November 2019.</recruitment_details>
      <pre_assignment_details>Five of 37 patients were excluded due to rescheduling, rapid sequence induction, prone position and different anesthetic medication. 3 patients in each group have missing data on duration of action due to supplementary doses of rocuronium.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Elderly (&gt;80 Years)</title>
          <description>16 patients planned for elective surgery above 80 years
Rocuronium: 0.6 mg/kg</description>
        </group>
        <group group_id="P2">
          <title>Younger (18-40 Years)</title>
          <description>16 patients planned for elective surgery between 18-40 years
Rocuronium: 0.6 mg/kg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Elderly (&gt;80 Years)</title>
          <description>16 patients planned for elective surgery above 80 years
Rocuronium: 0.6 mg/kg</description>
        </group>
        <group group_id="B2">
          <title>Younger (18-40 Years)</title>
          <description>16 patients planned for elective surgery between 18-40 years
Rocuronium: 0.6 mg/kg</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="16"/>
            <count group_id="B3" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="84" lower_limit="81" upper_limit="85"/>
                    <measurement group_id="B2" value="31" lower_limit="25" upper_limit="34"/>
                    <measurement group_id="B3" value="60" lower_limit="31" upper_limit="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>centimeters</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164" lower_limit="160" upper_limit="167"/>
                    <measurement group_id="B2" value="174" lower_limit="170" upper_limit="179"/>
                    <measurement group_id="B3" value="169" lower_limit="164" upper_limit="174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kilograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74" lower_limit="60" upper_limit="79.8"/>
                    <measurement group_id="B2" value="72.5" lower_limit="66" upper_limit="78.5"/>
                    <measurement group_id="B3" value="73.5" lower_limit="62.5" upper_limit="79.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ASA</title>
          <description>American Society of Anesthesiologists physical status was used to investigate if the two groups were similar concerning comorbidities.
ASA 1: no riskfactors or comorbidities ASA 2: slight riskfactors or/and comorbidites ASA 3: moderate riskfactors or/and comorbidities</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>ASA I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>ASA III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comorbidities</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Heart disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Liver disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Renal disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medication</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Any</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Loop-diuretics or thiazids</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of anesthesia</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164" lower_limit="127" upper_limit="194"/>
                    <measurement group_id="B2" value="146" lower_limit="128" upper_limit="189"/>
                    <measurement group_id="B3" value="154" lower_limit="127" upper_limit="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of surgery</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="16"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104" lower_limit="69" upper_limit="113"/>
                    <measurement group_id="B2" value="101" lower_limit="77" upper_limit="132"/>
                    <measurement group_id="B3" value="102" lower_limit="74" upper_limit="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Onset Time</title>
        <description>The time from the end of rocuronium injection to train-of-four (TOF) count of 0 monitored by acceleromyography.
The ulnar nerve was stimulated during the monitoring.</description>
        <time_frame>Day 0, after induction of anesthesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Elderly (&gt;80 Years)</title>
            <description>16 patients planned for elective surgery above 80 years
Rocuronium: 0.6 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Younger (18-40 Years)</title>
            <description>16 patients planned for elective surgery between 18-40 years
Rocuronium: 0.6 mg/kg</description>
          </group>
        </group_list>
        <measure>
          <title>Onset Time</title>
          <description>The time from the end of rocuronium injection to train-of-four (TOF) count of 0 monitored by acceleromyography.
The ulnar nerve was stimulated during the monitoring.</description>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="135" lower_limit="135" upper_limit="158"/>
                    <measurement group_id="O2" value="90" lower_limit="60" upper_limit="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparing onset time of rocuronium</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>40</ci_lower_limit>
            <ci_upper_limit>124</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>82</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon Mann-Whitney odd</method>
            <param_type>Odds</param_type>
            <param_value>19.48</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>95 % confidence interval is 7.63 to infinity</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparing Intubating Conditions in the Two Groups</title>
        <description>90 seconds after induction the conditions are rated by the Intubating Difficulty Scale (IDS).
Easy is defined as IDS of 0. Slight is defined as IDS of 1 to 5 Moderate/Major is defined as &gt;5</description>
        <time_frame>Day 0, after induction of anesthesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Elderly (&gt;80 Years)</title>
            <description>16 patients planned for elective surgery above 80 years
Rocuronium: 0.6 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Younger (18-40 Years)</title>
            <description>16 patients planned for elective surgery between 18-40 years
Rocuronium: 0.6 mg/kg</description>
          </group>
        </group_list>
        <measure>
          <title>Comparing Intubating Conditions in the Two Groups</title>
          <description>90 seconds after induction the conditions are rated by the Intubating Difficulty Scale (IDS).
Easy is defined as IDS of 0. Slight is defined as IDS of 1 to 5 Moderate/Major is defined as &gt;5</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Easy</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Slight</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate/Major</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Action</title>
        <description>Time from end of rocuronium injection to TOF ratio &gt;0.9. When the ratio between the first and last stimulation in TOF is above 90 %.</description>
        <time_frame>Day 0, after induction of anesthesia</time_frame>
        <population>3 in each group had missing data due to supplementary doses of rocuronium</population>
        <group_list>
          <group group_id="O1">
            <title>Elderly (&gt;80 Years)</title>
            <description>16 patients planned for elective surgery above 80 years
Rocuronium: 0.6 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Younger (18-40 Years)</title>
            <description>16 patients planned for elective surgery between 18-40 years
Rocuronium: 0.6 mg/kg</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Action</title>
          <description>Time from end of rocuronium injection to TOF ratio &gt;0.9. When the ratio between the first and last stimulation in TOF is above 90 %.</description>
          <population>3 in each group had missing data due to supplementary doses of rocuronium</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" lower_limit="71" upper_limit="97"/>
                    <measurement group_id="O2" value="53" lower_limit="42" upper_limit="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparing duration of action of rocuronium</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>31</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>14</ci_lower_limit>
            <ci_upper_limit>48</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparing duration of action of rocuronium</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>Wilcoxon Mann-Whitney odd</method>
            <param_type>Odds</param_type>
            <param_value>6.35</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>95% Confidence interval is 2.59 to infinity.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From induction of anesthesia to departure from the operating room.</time_frame>
      <desc>In both groups the patients will receive rocuronium in a dose aiming to provide optimal intubating conditions. It is not regarded as a disadvantage to use rocuronium, since the effect is monitored through surgery and if needed fully reversed by a reversal agent upon end of surgery.
It is an observational study why the patients mortality was not affected by the trial. Furthermore, patients at high risk for serious adverse events were excluded due to the criteria.</desc>
      <group_list>
        <group group_id="E1">
          <title>Elderly (&gt;80 Years)</title>
          <description>16 patients planned for elective surgery above 80 years
Rocuronium: 0.6 mg/kg</description>
        </group>
        <group group_id="E2">
          <title>Younger (18-40 Years)</title>
          <description>16 patients planned for elective surgery between 18-40 years
Rocuronium: 0.6 mg/kg</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.01</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Matias Vested</name_or_title>
      <organization>Rigshospitalet</organization>
      <phone>+4524464955</phone>
      <email>matiasvested@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

